TEVA-CLONAZEPAM
TEVA CANADA LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is TEVA-CLONAZEPAM discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that TEVA-CLONAZEPAM 2MG has been permanently discontinued (last updated October 19, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is TEVA-CLONAZEPAM not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RIVOTRIL
CHEPLAPHARM ARZNEIMITTEL GMBH
Other Products
PMS-CLONAZEPAM
PHARMASCIENCE INC
PMS-CLONAZEPAM-R
PHARMASCIENCE INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02239025
Strength
2MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
750MG · DIN 02247341
500MG · DIN 02247340
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
300MG · DIN 02370654